Drug – bio-affecting and body treating compositions – Lymphokine
Reexamination Certificate
2007-10-30
2010-02-23
Li, Ruixiang (Department: 1646)
Drug, bio-affecting and body treating compositions
Lymphokine
C530S351000
Reexamination Certificate
active
07666401
ABSTRACT:
The present invention relates to a G-protein coupled receptor and a novel ligand therefor. The invention provides screening assays for the identification of candidate compounds which modulate the activity of the G-protein coupled receptor, as well as assays useful for the diagnosis and treatment of a disease or disorder related to the dysregulation of G-protein coupled receptor signaling.
REFERENCES:
patent: 5948664 (1999-09-01), Williams et al.
patent: 6822072 (2004-11-01), Edwards et al.
patent: 2003/0022188 (2003-01-01), Macina et al.
patent: 2003/0096299 (2003-05-01), Wittamer et al.
patent: 2005/0084936 (2005-04-01), Lal et al.
patent: WO/00/31258 (2000-06-01), None
patent: WO/02/03789 (2002-01-01), None
Adams et al.; “1,25 Dihydroxyvitamin D3 and Dexamethasone Induce the Cyclooxygenase 1 Gene in Osteoclast-Supporting Stromal Cells”; J. of Cellular Biochemistry; 74:587-595, 1999.
Nagpal, et al.; “Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin”; (1997); J. Invest. Dermatol.; 109: 91-95.
Samson et al.; “ChemR23, a putative chemoattractant receptor is expressed in monocyte-derived denritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strains”; (1998); Eur. J. Immunology; 28: 1689-1700.
Methner, et al.; “A novel G protein-coupled receptor with homology to neuropeptdie and chemoattractant receptors expressed during bone development”; (1997); Biochemical and Biophysical Research Communications; 233: 336-342.
Kotani et al. “the metastasis-suppressor gene KiSS-1 encodes kisspeptins, the natural ligans of the orphan G protein-coupled receptor GPR54”, (2001), J. Biol. Chem. 276: 34631-34636.
Joost, P. et al. “Phylogenetic analysis of 277 human G-protein-coupled receptors as a tool for the prediction of orphan receptor ligands”, (2002), Genome Biology 3, 0063.1-0063.16.
Lee et al., “Orphan G protein-coupled receptors in the CNS”, (2001), Curr. Opin. Pharacol., 1:31-39.
Im et al., “Orphan G protein-coupled receptors and beyond”, (2002), Jpn. J. Pharmacolo., 90: 101-106.
Communi et al., “Receptors responsive to extracellular pyrimidine nucleotides” Trends in Pharmacological Sciences, 18(3): 83-86, Mar. 1, 1997.
Communi et al., “Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenyl cyclase” J. Biol. Chem. 272(51):31969-31973, 1997 .
Owman et al., “Molecular cloning and tissue distribution of a novel chemo-attractant-like receptor,” Biochem Biophys Res. Commun., Dec. 1997, 18:241(2)390-4.
International Search Report, Oct. 22, 2003, PCT/EP2002/07647.
Wittamer et al., Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids, the journal of experimental medicine, Oct. 6, 2003, vol. 198, No. 7, pp. 977-985.
Wittamer et al., “The C-terminal nanopeptide of mature chemerin activates the chemerin receptor with low nanomolar potency,” The J. of Biological Chemistry, Mar. 12, 2004, vol. 279, No. 11, pp. 9956-9962.
International Search Report, Oct. 25, 2005, PCT/EP2004/006945.
Brezillon Stephane
Communi David
Detheux Michel
Franseen Jean-Denis
Lepoul Emmanuel
DeCloux Amy
Euroscreen S.A.
Li Ruixiang
McCool Gabriel J.
Williams Kathleen
LandOfFree
Compositions comprising a ligand of Chemerin R does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions comprising a ligand of Chemerin R, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions comprising a ligand of Chemerin R will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4158194